https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-Imfinzi-tremelimumab-granted-ODD-in-liver-cancer-29862265/?utm_source=telegram&utm_medium=social&utm_campaign=share